Search Result "daclatasvir/sofosbuvir"
Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
Journal: Current Drug Safety
Volume: 15 Issue: 1 Year: 2020 Page: 53-60
Author(s): Lamiaa N. Abdelaty,Ahmed A. Elnaggar,Amira A. Said,Raghda R.S. Hussein
Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway
Journal: Current Molecular Pharmacology
Volume: 13 Issue: 4 Year: 2020 Page: 318-327
Author(s): Sherin Zakaria,Alaa E. El-Sisi
Real Life Egyptian Experience of Daclatasvir Plus Sofosbuvir with Ribavirin in Naïve Difficult to Treat HCV Patients
Journal: Infectious Disorders - Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 43-48
Author(s): Engy A. Wahsh,Amal K. Hussein,Ahmed A. Gomaa,Mohamed A. Baraka,Mohie Al-deen Abead
Comparative Real Life Egyptian Experience of the Combination of SofosbuvirPlus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic PatientsInfected with HCV Genotype 4
Journal: Current Drug Safety
Volume: 18 Issue: 2 Year: 2023 Page: 207-213
Author(s):
Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study
Journal: Current Drug Safety
Volume: 13 Issue: 3 Year: 2018 Page: 187-195
Author(s): Eman I. Ahmed,Wafaa Y. Abdel Wahed,Essam A. Hassan,Tarek I. Ahmed
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 30 Year: 2013 Page: 3733-3742
Author(s): I. Gentile,F. Borgia,A. R. Buonomo,G. Castaldo,G. Borgia
Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic Chronic HCV Non-cirrhotic Treatment-Naïve Egyptian Patients Eradicated with Sofosbuvir Plus Daclatasvir
Journal: Current Diabetes Reviews
Volume: 16 Issue: 2 Year: 2020 Page: 165-170
Author(s): Hany Aly Hussein,Ahmed Samir Allam,Ahmed Samir Abdel Moaty
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 12 Year: 2014 Page: 1391-1404
Author(s): I. Gentile,F. Borgia,N. Coppola,A.R. Buonomo,G. Castaldo,G. Borgia
Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues
Journal: Current Drug Targets
Volume: 18 Issue: 7 Year: 2017 Page: 851-862
Author(s): Jordan J. Feld
Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
Journal: Current HIV Research
Volume: 15 Issue: 6 Year: 2017 Page: 422-433
Author(s): Giuseppe Bruno,Annalisa Saracino